Israel Englander’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-30,000
| Closed | -$1.24M | – | 7166 |
|
|
2022
Q4 | $1.24M | Buy |
30,000
+10,000
| +50% | +$405K | ﹤0.01% | 3951 |
|
|
2022
Q3 | $876K | Buy |
20,000
+10,000
| +100% | +$485K | ﹤0.01% | 4451 |
|
|
2022
Q2 | $492K | Buy |
+10,000
| New | +$536K | ﹤0.01% | 4971 |
|
|
2020
Q3 | – | Sell |
-30,000
| Closed | -$1.67M | – | 4937 |
|
|
2020
Q2 | $1.67M | Buy |
+30,000
| New | +$1.74M | ﹤0.01% | 2654 |
|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$773K | – | 4693 |
|
|
2019
Q4 | $773K | Sell |
10,000
-20,000
| -67% | -$1.41M | ﹤0.01% | 3125 |
|
|
2019
Q3 | $1.9M | Buy |
+30,000
| New | +$1.88M | ﹤0.01% | 2478 |
|
|
2019
Q2 | – | Sell |
-35,900
| Closed | -$2.04M | – | 4603 |
|
|
2019
Q1 | $2.04M | Buy |
+35,900
| New | +$1.91M | ﹤0.01% | 2394 |
|
|
2018
Q4 | – | Sell |
-10,000
| Closed | -$710K | – | 4306 |
|
|
2018
Q3 | $710K | Hold |
10,000
| – | – | ﹤0.01% | 3062 |
|
|
2018
Q2 | $521K | Buy |
+10,000
| New | +$524K | ﹤0.01% | 3148 |
|
|
2014
Q3 | – | Sell |
-154,900
| Closed | -$5.51M | – | 4084 |
|
|
2014
Q2 | $5.51M | Buy |
+154,900
| New | +$5.3M | 0.02% | 1158 |
|
Other funds holding NUVA
Israel Englander's NUVA Position: Q3 2023 in Review
Israel Englander sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 71,324 shares — an estimated $2.97M sold.
Israel Englander first reported a position in NUVA in Q2 2013 and held it in 40 quarters. The position peaked at $95.2M in Q2 2015. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Israel Englander reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Israel Englander sold 71,324 NuVasive, Inc. shares in Q3 2023, an estimated $2.97M.
- Israel Englander first reported a position in NuVasive, Inc. in Q2 2013 and held it in 40 quarters.
- Israel Englander's NuVasive, Inc. position peaked at $95.2M in Q2 2015.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.